La barrière hémato-encéphalique lors de l’ischémie cérébrale : une cible thérapeutique
- 22 November 2012
- journal article
- abstracts
- Published by EDP Sciences in Biologie Aujourd'hui
- Vol. 206 (3) , 161-176
Abstract
Since it was discovered and its brain-protective role characterized, the blood-brain barrier (BBB), through the permeability-restricting action of the brain capillary endothelial cells, has been representing a hurdle for 95% of new medical compounds targeting the central nervous system. Recently, a BBB dysfunction is being found in an increasing number of pathologies such as brain ischaemic stroke, whose only therapy consists in a pharmacological thrombolysis limited to a small percentage of the admitted patients, because of the toxical effects of thrombolytics. And since the clinical failure of promising neuroprotectants, numerous studies of brain ischaemia were carried out, with physiopathological or pharmacological approaches refocused on the BBB, whose structural complexity is now expanded to perivascular cells, all forming a functional unit named the neurovascular unit (NVU). Nevertheless, in spite of the numerous molecular mechanisms identified, the process of BBB dysfunction in the ischaemia/reperfusion cascade remains insufficiently established to explain the pleiotropic action exerted by new pharmacological compounds, possibly protecting the entire NVU and representing potential treatments.Keywords
This publication has 101 references indexed in Scilit:
- Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical useThe Lancet Neurology, 2009
- Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemiaBritish Journal of Pharmacology, 2009
- Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled studyThe Lancet Neurology, 2009
- Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemiaNeuroscience, 2009
- Cellular and Molecular Neurobiology of Brain PreconditioningMolecular Neurobiology, 2009
- Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic strokeNature Medicine, 2008
- Cross-talk Between Statins and PPARα in Cardiovascular Diseases: Clinical Evidence and Basic MechanismsTrends in Cardiovascular Medicine, 2008
- Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possiblyBritish Journal of Pharmacology, 2008
- PPARs and molecular mechanisms of transrepressionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Statins and StrokeJournal of Cerebral Blood Flow & Metabolism, 2005